Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

LONG-TERM FOLLOW-UP OF THE COPELAND RESURFACING HEMI-ARTHROPLASTY IN A DISTRICT GENERAL HOSPITAL

The South West Orthopaedic Club (SWOC)



Abstract

We evaluated the long-term survival and patient reported outcome of the Copeland mark III humeral resurfacing hemi-arthroplasty (Biomet, Warsaw, Indiana).

At a UK District General Hospital 95 shoulder replacements in 85 patients were performed from 1994 to 2003 (mean age 68.9). At the time of follow-up (mean of 12 years, range 8.7–18.0) 49 patients had survived. This study group were posted Oxford Shoulder Score (OSS) and SF-12 questionnaires and their case notes were reviewed.

There was an 82% response rate. The responders comprised 46 shoulders in 40 patients. 40 shoulders had a pre-operative diagnosis of osteoarthritis and 6 had other pathologies. The median OSS was 36. The median functional score was 24 (IQR: 9.5), where 32 is the best. The median pain score was 13 (IQR: 7) with 16 being the best score. There was a median SF 12 score of 31 (IQR: 3), where the maximum score is 47. There were 3 revision operations and 95% survivorship at 18 years, according to Kaplan Meier survival analysis.

The Copeland mark III hemi-arthroplasty prosthesis has a good long term survival, few post-operative complications and a good functional outcome in an elderly population. We would advocate its use in this patient group.